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1 and gD-2 coding sequences fused to the lacZ gene.
Such hybrid genes were expressed in a regulated man ner in E. coli by joining them to the lac promoter operator region. Efficient translation of these hybrid genes was facilitated by incorporating a coding sequence specifying a short peptide leader (>.cro) in the plasmid expression vectors resulting in synthesis of chimeric Cro-gD-�-galactosidase proteins. In addition, insertion of synthetic translation terminators at the junction of gD and lacZ enabled us to produce specific truncated gD polypeptide sequences unfused to tJ-galactosidase.
The gD antigens produced in E. coli were not glyco sylated and were generally recovered as dense insoluble aggregates. Proteins containing portions of gD-I or gD-2 were analyzed by immunoprecipitation using anti HSV rabbit serum and a number of monoclonal antibod ies recognizing different epitopes of gD-l. Initial animal studies were done with antigens that reacted with neu tralizing antisera or monoclonal antibodies. When these bacterially produced proteins were injected into rabbits, antibodies were produced that specifically immunopre cipitated authentic gD polypeptides and neutralized the infectivity of both virus types. These studies suggest that gene fusion techniques can be used to produce im munogenic proteins in large quantity. These polypep tides are not only useful in analyses of gene structure and function, but also can provide novel diagnostic re agents and well-defined pure antigens for vaccine de velopment.
The general use of purified proteins from important viruses of medical significance for diagnostic reagents, experimental tools, and subunit vaccines has been slowed or made impossible because samples of sufficient quantity, high purity, reproducible quality, and defined structure were difficult to obtain. Advances in modern biology have made the picture much more sanguine_ For example, chemical synthesis of peptides provides a source of antigens of defined and p redetermined structure [1] . In addition, the use of monoclonal antibodies facilitates identifi cation of specific protein segments and makes possible high level purification of polypeptides [2] . Finally, recombinant DNA technology simplifies the analysis of viral gene structure Reprint requests to: Dr. Roger J. Watson and function and also makes possible the inexpensive commer· cial production of many important proteins. It is a particular use of this latter technology, the construction of protein fusions, that is the subject of this report.
The lactose (lac) operon of E. coli has played a central role in molecular biology [3] . It represents one of the best under stood biological regulatory systems and has provided E. coli molecular biologists with an enviable set of reagents. Until recently, the general use of this knowledge and material was severely limited. However, with the recognition of translocat able elements and the advent of recombinant DNA technology, it is now possible to fuse virtually any ge ne, regardless of its function, to the control region of the lac operon (operon fusion)
or to the first gene of the operon, lacZ (protein fusion) [4] . Consequently, many of the phenotypes of lac, so well and carefully detailed in the past 30 years, can be conferred to any gene.
In this report, we will demonstrate the use of fusions to elements of the lac operon in the analysis of the glycoprotein D genes of herpes simplex virus type s 1 and 2. Our purpose is twofold: first, to demonstrate some of the potential of gene fu sion technology and E. coli molecular biology for production and analysis of herpes simplex antigens, and second, to docu· ment our progress to date on production of defined antigens for potential use in prophylaxis and therapy of herpes simplex virus infections.
MATERIALS AND METHODS

Techniques
Bacterial strains, plasmids, and specific recombinant DNA methods are as described previously [5] [6] [7] . General principles and methods for work with gene fusions in E. coli are presented in Silhavy et al. [8] .
The lac Operon
The lac operon of E. coli contains three genes, the first two of which encode proteins required for growth on lactose. The first gene of the operon is the lacZ gene specifying the enzyme {:i-galactosidase, which hydrolyzes the disaccharide lactose into glucose and galactose. The second gene of the operon is the lacY gene specifying a membrane bound permease that actively transports lactose and its analogues into the cell. The operon is negatively controlled at the level of transcription by a repressor, the product of the lacI gene. The repressor can be inactivated by the addition of lactose or its analogues.
The laeZ gene product (the enzyme {:i-galactosidase} is one of the largest and most genetically malleable proteins in E. coli. The enzyme is a tetramer of four identical subunits, each with a molecular weight of 116,000 [9] . This unusually stable enzyme can withstand boiling for 10 minutes with retention of 30% activity and survives extensive trypsin digestion with almost no loss of activity. The peptide backbone is sensitive to these treatments, but the many disulfide bridges and noncovalent interactions hold the enzyme in a highly stable confor mation [10] . The amino-terminal portion of each subunit is involved in tetramerization, and the carboxy-terminal portion functions in hy drolysis of i1-galactosides [4] . An important feature of i1-galactosidase essential for its use in protein fus ion technology is that almost any amino acid sequence can be substituted for the authentic amino· terminal sequences without destroying enzyme activity [11] . However, no more than 26 amino acids of the authentic amino terminals can be removed from i1-galactosidase without permanent loss of enzymatic activity [ 4] . This rather phenomenal property enables one to fuse por-
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tions of, or entire genes, to lacZ and still retain {:I-galactosidase activity in the hybrid protein. The enzyme activity can be simply assessed in colonies using indicator media such as lactose-MacConkey agar or lactose-tetrazolium agar. Other indicator media and chromogenic sub strates have been described [4, 12] .
Protein Fusion Expression Vectors
There are two basic strategies for expression of foreign genes in E. coli. In one, a bacterial transcription control sequence is fused to a Open boxes indicate the relative positions of coding sequences specifying the Cro leader (cro), the lael/Z fusion, and {:I lactamase (which confers ampicillin resistance upon bacteria trans formed with the plasmid). The cro and lael/Z sequences are transcribed clockwise under the transcriptional control of the lac promoter-operator lIac pia). The poly linker sequence contains three unique restriction sites (BgllI-SrnaI-BamHI) at which DNA sequences to be expressed can be cloned. Translation of fusion proteins initiates at ATG and terminates at TAA. The origin of replication (ori) is required to initiate plasmid DNA synthesis in E. coli. Fusion proteins made in this way are formally analagous to synthetic peptides coupled to protein carriers: gD peptides are "coupled" to the {:I-galactosidase carrier as a result of gene fusions_ Specific fusions to {:I-galactosidase or Cro can be made at the sites within the gD coding sequence to produce genes of defined truncation. Similarly, internal deletions or site-directed mutagenesis can alter specific regions or sites by design. In this way, a collection of antigens can be prepared in quantity with defined primary structure and reproducible quality.
TR L UL
RESULTS
The Glycoprotein D Genes of HSV-J and HSV-2 Herpes simplex types 1 and 2 virions contain at least four glycoproteins in their respective viral envelopes [13) . The struc ture and function of these polypeptides and their genes are of interest because they are involved in absorption, viral morpho genesis, and cell-to-cell interaction and probably are the pri mary contacts with the host immune system [14, 15) . begun our studies with the gD polypeptides because several lines of evidence indicate that gD is the major immunogen of the virus and is found in the cell membranes in abundance after infection [14, 16) . The structural genes of gD -l and gD-2 are in essentially the same location in the genome [17] . It has been established that while each polypeptide has a number of distinct antigenic determinants, certain epitopes are shared in common [14) . We have subsequently characterized the gD-1 mRNA and have completely sequenced both the gD-1 and gD -2 structural genes [5, 18, 19) . These analyses proved that both gD genes are closely related and that there are no introns within either gD coding sequence. The lack of introns facilitated our work with lac gene fusions because it allowed us to work directly with genomic DNA rather than with a cDNA copy.
The location and restriction maps of the gD -1 and gD-2 coding regions are shown in Fig 2. Analysis of the DNA se quence indicated that the gD-1 coding region could encode a protein of 394 amino acids and that of gD-2 one of 393 amino acids. By examination and comparison of the deduced amino acid sequences, it was obvious that both proteins shared the general structure of a typical membrane glycoprotein. The key features included a signal peptide sequence, a large main body, a transmembrane sequence, and a charged anchor sequence. For ease of analysis, we divided the protein sequences into three parts: the signal peptide sequence, the main body, and the transmembrane-anchor region. The signal peptide sequences are removed during maturation of gD-1 and gD -2, presumably during passage of the glycoprotein through a membrane. By comparing the deduced amino acid sequences of gD -1 and gD- character of both peptides remains highly conserved (Fig 3) .
Such conservation most probably reflects similar requirements for each signal peptide in membrane transport and processing. The second region of the gD glycoproteins is the main body. A direct comparison of the amino acid sequences of these regions from gD-l and gD-2 is presented in Fig 4. This segment begins with amino acid 26 of the deduced sequence (the first amino acid of the mature sequence) and ends with a sequence defined by a hydrophobic alpha-helical region predicted in both gD -l and gD -2 that begins 55 residues from the carboxy ter· minal. This hydrophobic region probably represents the por· tions of each polypeptide that span the lipid bilayer. If this general structure is correct, then 314 amino acids of gD·! (residues 26-339) and 313 amino acids of gD-2 (residues 26-338) would be located external to the viral envelope. These external segments, therefore, are likely to be the only portions of either gD polypeptide accessible to the immune system and involved in cell-virus or infected-cell interactions. In contrast to the signal peptides, the external-body sequences are highly conserved. There are only 37 residue changes out of 314, plus one amino acid deletion, in gD-2. There are several common fe atures that bear special note. First, both polypeptides have three predicted glycosylation sites in precisely the same loca· tion. The predicted N-linked glycosylation sites (asparagine· X-serine or asparagine-X-threonine) are indicated by branched structures in Fig 4. Second, both polypeptides have six cysteine residues, expected to be involved in specific folding through disulfide linkages, located in the same positions (filled circles below the line in Fig 4) . Finally, both polypeptides contain an abundance of proline residues. The main body of gD-1 contains 39 and that of gD -2 contains 37. These residues impose major structural constraints on protein conformation. It is significant, therefore, that the position of 33 of the 39 proline residues in gD -1 is conserved in gD -2 (boxed residues in Fig 4) .
The third region of both glycoproteins to be considered is the transmembrane-anchor region defined by the carboxy-ter· minal 55 amino acids. The comparison of the deduced amino acid sequences is given in Fig 5. The first 25 residues represent the protein portion predicted to span the lipid bilayer, and the last 30 amino acids represent the highly charged portion that presumably functions to anchor each glycoprotein to the memo brane. Like the signal peptide sequence, this region is more variable in sequence than the main body. In the 55 residues shown, the gD -2 sequence differs from the gD -1 sequences in 17 positions. Nevertheless, the local hydrophilicity of both peptides is remarkably similar (Fig 5) . The hydrophobic nature of the putative transmembrane region is in marked contrast to the highly charged and hydrophilic nature of the terminal anchor sequence.
Construction of Expression Plasmids Containing gD Sequences
We have used the expression vector pJS413 to construct plasmids that specify two types of' gD-related proteins in E, coli. In one type of plasmid, exemplified by pEH25, the pJS413 cro leader sequence was ligated with gD coding sequences so that they were in the same translational reading frame (Fig 6,  A) . The hybrid coding sequences initiated at the era ATG codon and terminated at the gD TAG codon. Such hybrid genes were placed under the transcriptional control of the pJS413lac promoter-operator. The construction of pEH25 resulted in deletion of gD-1 DNA encoding 52 amino-terminal amino acids -ss--t:r---tt---V-l �rr -ACr�SI 
( Fig 6, C) . The sequence deleted included the entire 25 amino acid signal peptide coding region. In other constructions (pEH51 and pEH71; Fig 6, C) , fewer amino-terminal coding sequences of gD-l were deleted. Plasmid pEH51 contains gD-l DNA encoding all but the initial 6 amino acids of the signal peptide, whereas pEH71 encodes a Cro-gD-l protein including all but 32 amino-terminal residues of gD-l. As the signal peptide sequence is proteolytic ally removed in maturation of gD-l, pEH71 contains all but 7 amino-terminal residues of mature gD-l.
In the other type of expression plasmid, exemplified by 360 370 380 390 394
pEH4-2, the cro-gD sequences contained by the plasmids de scribed above were ligated to the lacljZ gene of pJS413 to form a continuous cro-gD-lacljZ coding sequence (Fig 6, B) . In the construction of pEH4-2, the carboxy-terminal gD-l coding sequences of pEH25 were removed by digestion with Bal31 exonuclease. DNA fragments having between 40 and 240 bp of gD-l sequences deleted were isolated by preparative agarose gel electrophoresis. Ligation of these DNA fragments to a pJS413 backbone generated a population of plasmids containing vari ably deleted gD-l DNA fused to the amino-terminal lacljZ coding sequence. Since there are three potential translational 106s WATSON ET AL reading frames, only one in three of these plasmids would be expected to have the correct cro-gD-lacl/Z reading frame. Therefore, E. coli containing this plasmid population were screened by replica-plating on lactose-MacConkey agar plates. Cells transformed with plasmids specifying a Cro-gD-j3-gal protein were red on these indicator plates because such chimeric proteins retain j3-galactosidase activity. A number of plasmids specifying chimeric proteins were selected in this way. These include the gD-l containing plasmids pEH4-2, pEH4-1, pEH90-5, and pEH90-10. As shown in Fig 6 , C, these plasmids contain the same Cro-gD-l fusion as pEH25, but differ in the amount of carboxy-terminal gD-l sequences deleted. The gD-l sequences deleted in pEH4-2 include the entire transmem brane-anchor coding region, whereas pEH4-1 specifies a protein containing the transmembrane sequence and 7 amino acids of the anchor sequence. Plasmids specifying Cro-gD-l-j3-gal proteins containing ad ditional amino-terminal gD-l sequences were constructed as follows: Plasmids pEH81 and pEH82 were generated by ligating DNA fragments containing the amino-terminal coding region ofpEH51 to a fragment containing the carboxy-terminal coding sequence of pEH4-1 and pEH4-2, respectively. Likewise, pEH83 and pEH84 were constructed by ligation of a pEH71 DNA fragment with pEH4-1 and pEH4-2 DNA fragments. In this way, we have made a battery of plasm ids that specify chimeric proteins containing different components of the gD-l Vol. 83, No.1 Supplement polypeptide (Fig 6, C) . In addition, we have constructed a plasmid, pHV -6, that specifies a chimeric protein containing gD-2 sequences (Fig 6, C) . We will describe below the applica· bility of these various plasmid expression systems to produce antigens of defined specificity in E. coli.
Expression of gD Sequences in E. coli
The Cro-gD-1 and Cro-gD-1-j3-gal proteins specified by pEH25 and pEH4-2, respectively, were examined using anti bodies directed against authentic virus-encoded gD-l to assess the immunologic integrity of the bacterially produced polypep· tides. We have previously reported that rabbit anti-HSV·l serum and a number of monoclonal antibodies directed against gD-l immunoprecipitate both the pEH25 and pEH4-2 proteins [5, 6] . As shown in Fig 7, both proteins react with rabbit anti· HSV -1 serum in a Western blot analysis. Duplicate 1 -ml cultures of both pEH25 and pEH4-2 transformants were grown to late logarithmic phase; then one culture of each was induced by adding IPTG to 1 mM. After incubation for a further 1 h at 3TC, the bacteria were pelleted by centrifugation and resus· pended in sample buffer. The samples were boiled and the proteins resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Following electrophoresis, the proteins were transferred electrophoretically to nitrocellulose. Proteins bound to the membrane were reacted successively with either gO termination A. 
B.
I.
., .. ----- rabbit anti-H8V-l serum or the 558 monoclonal antibody and then m I-labeled goat anti-rabbit IgG or rabbit anti-mouse IgG antibodies. Reaction of these antibodies to the pEH25 and pEH4-2 proteins was visualized by autoradiography of the nitrocellulose sheet. It was apparent from this experiment (Fig   7) that small amounts of these proteins were made in the absence of the lac inducer, IPTG. Significantly greater amounts were synthesized in its presence, however. It is noteworthy that the 55S monoclonal antibody [20] reacted with the Cro-gD -1 protein specified by pEH25, but did not react with the pEH4-2 Cro-gD-l-iJ-gal protein (Fig 7) . The gD-l sequences of pEH4-2 differ from those of pEH25 in that the carboxy-terminal 69 amino acids are deleted as a result of the fusion to iJ-galacto sidase. This result, therefore, indicates that the 55S epitope lies in the carboxy-terminal region of gD-l. In support of this interpretation, we have found that synthetic peptides compris ing the carboxy-terminal 33 peptides of gD-1 react with the 55S monoclonal antibody in an ELISA assay (results not shown). It appeared in the Western blot analysis that the pEH25 and pEH4-2 proteins were present in approximately equimolar amounts following the l-h induction period. The similar inten sity of the bands observed, however, more probably reflects the reactivity in the Western blot procedure of gD-l carboxy-
BACTERIAL EXPRESSION OF HSV gD
1078
terminal sequences unique to the pEH25 protein, since we have consistently observed little accumulation of the Cro-gD-1 pro tein in this induction period, whereas the Cro-gD-l-iJ-gal pro tein represented a significant percentage of the total E. coli cell protein (approximately 2-4 %). Indeed, we have observed that the carboxy-terminal gD-l sequences contained by pEH25 are deleterious for expression of this foreign protein in E. coli [7] .
A further demonstration of those gD-! sequences affecting the level of accumulation of Cro-gD-l-iJ-gal proteins in E. coli is described below.
The gD-1 DNA sequences contained by plasmids pEH4-2 and pEH4-l and their derivatives pEH81, pEH82, pEH83, and pEH84 are described above (see also Fig 6, C) . Overnight plasmid-containing cultures were diluted 1/20 to duplicate tubes of 1 ml of L broth. One of each pair of cultures was induced with IPTG (1 mM final concentration), and both cultures were then incubated at 37'C for 6 h. The cells were collected by centrifugation and lysed by boiling in sample buffer, and the proteins were resolved by SDS-PAGE. Coom assie blue staining of the gel (Fig 8) revealed that pEH4-2, pEH84, and pEH82 made large quantities of Cro-gD-1-iJ-gal (approximately 10% of the total cell protein) upon IPTG in duction. This result indicated that the signal peptide sequences contained by pEH82 and the additional amino-terminal coding sequences contained by pEH84 had no effect on the level of accumulation of these Cro-gD-1-iJ-gal proteins. In contrast, very little of the pEH4-1, pEH83, and pEH81 proteins were found to accumulate even with IPTG induction (Fig 8) . This result again demonstrated that the additional carboxy-terminal gD-1 sequences present in each of these plasmids, which include the transmembrane sequences and seven amino acids of the anchor sequence, are deleterious for expression in E. coli. It is noteworthy that IPTG induction of these latter cultures had an adverse effect on cell growth, resulting in decreased amounts of all E. coli polypeptides. The deleterious effect of carboxy terminal gD-1 sequences on accumulation of Cro-gD-1-iJ-gal proteins may be explained, at least in part, by the toxic nature of this amino acid sequence.
We previously observed that accumulation of the pEH4-2 Cro-gD-1-iJ-gal protein in E. coli resulted in, or perhaps was dependent on, the fo rmation of dense, insoluble aggregates in the cytoplasm of the cell. The formation of aggregates seems to be a general property of iJ-galactosidase fusion proteins [21] . We have demonstrated that the Cro-gD-1-iJ-gal protein specified by pHV6 also forms these aggregates. As shown in Fig 9 , this protein comprises a significant proportion of the total cell protein in IPTG-induced cells transformed with pHV6. Disruption of induced cells with lysozyme and nonionic detergent treatment followed by separation of particulate ma terial from soluble material by pelleting through a sucrose pad resulted in almost exclusive partition of the fusion protein in the pellet fraction (Fig 9) . The property of aggregation makes it possible to obtain a reasonable purification of the iJ-gal fusion protein in one step simply by disruption of cells and centrifu gation. Higher levels of purification may be obtained by resus pending the pellet by sonication and pelleting again.
We have reported previously on the immunogenic properties of pEH4-2 and pHV6 chimeric proteins in rabbits [6, 7] . These proteins were prepared as immunogens by separating aggregate purified polypeptides by SDS-PAGE, excision of the appropri ate gel slice, and maceration. Rabbits were inoculated subcu taneously several times in all with 100-200 Ilg of the fusion protein emulsified in complete Freund's adjuvant. Antibodies were raised that recognized the cognate virus-encoded glyco protein in various immunologic assays. Antibodies raised against the pEH4-2 protein immunoprecipitated both gO-1 and gD -2 and also neutralized in vitro the infectivity of both HSV l and HSV-2. Antibodies raised against the pHV6 protein likewise neutralized both HSV-1 and HSV-2 infectivity [7] . While all anti-pHV6 protein sera immunoprecipitated gD-2, only certain sera immunoprecipitated the heterologous gD-j [7] . Using these immunogens, it was generally observed that the resultant antisera had a higher neutralizing titer against the homologous virus type, indicating that these chimeric pro te ins contain both type-specific and type-common antigen ic determinants.
Preparation of Immunogens Unfu.�ed to tJ-galactosidase
Although we have demonstrated the immunogenicity of gD containing tJ-galactosidase fu sion proteins in rabbits, the prob ability existed that fusion proteins may not be acceptable for use as immunogens in humans. We have devised a general scheme, therefore, to make Cro-gD proteins unfused to p galactosidase in high yields in E. coli. To do so, it was necessary to both delete the toxic carboxy-terminal sequences of gD-j and to protect the resultant truncated Cro-gD-l protein against the very active proteolytic system of E. coli. These goals were conveniently achieved by expressing a truncated Cro-gD-1 pro tein in concert with a Cro-gD-l-tJ-gal protein as described be low.
Plasm ids having in-phase fu sions of cro-gD-1 sequences with the lacl/Z gene were made using the vector pHK414. This vector is identical to pJS413 except that it has a polylinker containing the restriction sites BglII-HindIII-SmaI-BamHI between the cro and lacl/Z segments (Fig 1 and Fig 10, A) . In construction of these plasmids, Bal31-randomized carboxy-ter· minal gD-l DNA was ligated to the filled in BglII terminal of pHK4l4, resulting in a set of plasmids (the pEH90 series) containing the sites HindIII-SmaI-BamHI at the gD-1-tl-gal junction (Fig 10, B) . E. coli strain NF1829 was transformed with the pEH90 series and plated on rich medium wit h no lactose. The resulting colonies were screened by replica plating to lactose-MacConkey agar plates and picking the red Lac· colonies. The gD-l carboxy-terminal end points in plasm ids obtained from these transformants were determined by DNA sequencing. Here we will report on studies with the isolates pEH90-5 and pEH90-1O (Fig 6, C) . These plasmids have the same cro-gD-1 fusion point as pEH4-2. Plasmid pEH90-5 has D. vided a convenient way to precisely insert at the junction a synthetic DNA sequence with cohesive HindlII and BamHI terminals. As shown in Fig 10, C, this particular synthetic DNA sequence contains a termination codon (TAG, amber). The linker sequence was designed to retain the translational phasing of the cro-gD-l and lacl/Z sequences and to terminate trans lation of the gD -1 coding sequence with the amber codon. E. coli strain NF1829 transformed with plasmids containing this amber linker (pEH90-5am and pEH90-10am) had a pink colony phenotype on lactose-MacConkey indicator agar in contrast to the red colony phenotype of their progenitors. This is consistent with our expectation that these plasmids would specify trun cated Cro -gD proteins and not {:i-gal fusion proteins. The fi nal step to create a high-level expression system for this truncated Cro-gD polypeptide was to transfer the amber codon containing plasmids into a strain encoding an amber suppressor tRNA. The particular strain chosen was LE392, which contains two amber suppressor genes (supE and supF). The mutant tRNAs specified by these genes will insert gluta mine (supE) or tyrosine (supF) in the growing polypeptide chains at positions specified by the amber termination codon. These suppressor tRNAs, therefore, allow translational read through of the synthetic termination codon. However, suppres sion or read-through is significantly less than 100%. The effi ciency of supE suppression has been estimated at 14% and that of supF at 55% [22] . We predicted, therefore, that expression of pEH90-5am and pEH9-lOam in E. co li LE392 should result in a mixture of Cro-gD-l truncated protein (from termination at the amber codon) and Cro-gD-1-{:i-gal (from read-through of the amber codon and termination at the {3-gal terminator codons (see Fig 10, D) . This prediction was tested as follows.
Overnight 1-ml cultures of E. coli NF1829 transformed with pEH90-5, pEH90-1O, pEH90-5am, and pEH90-lOam and E. coli LE392 transformed with pEH90-5am and pEH90-10am were used to inoculate 50 ml of L broth. IPTG was added to 1 mM and the cultures were incubated at 37°C for 7 h. The cells were collected by centrifugation and lysed with lysozyme fo l lowed by nonionic detergent treatment. The soluble proteins were separated from protein aggregates by centrifugation, and equivalent amounts of each supernatant and pellet fraction were analyzed by SDS-PAGE. Coomassie Blue staining of the gel (Fig 11) indicated that the pEH90-5 and pEH90-10 Cro gD -1-[:i-gal proteins were present in the pellet fraction only, as expected. In E. coli NF1829 cells transformed with pEH90-5am and pEH90-lOam, the Cro-gD-1-{3-gal protein was not observed in either the supernatant or pellet fractions, indicating that there was no significant read-through of the amber codon. In contrast, in E. coli LE392 transformed with these plasmids, large amounts of this chimeric protein were made, indicating that the amber codon was being translated as predicted. In addition, in E. coli LE392, but not in E. coli NF1829, proteins of sizes consistent with those predicted of the truncated Cro gD -1 polypeptides were present in the pellet fraction only ( Fig   11) . As expected, the putative Cro-gD-1 protein specified by pEH90-5am was larger than that specified by pEH90-lOam. We have confirmed that these proteins are authentic Cro-gD-1 polypeptides by Western blot analysis [7] .
The experiment described above demonstrated that gD -1-related proteins unfused to {3-galactosidase can be produced in a stable form in E. coli. We have found that such truncated amber fragments are unstable when synthesized in E. coli NF1829 and are stabilized by synthesizing the {:i-galactosidase fusion protein in concert. The truncated Cro-gD-l proteins in E. coli LE392 may be partially purified by virtue of their property of aggregation. These proteins often constitute as much as 3% of the total cell protein. Their potential use as immunogens has been studied as fo llows.
Aggregate-fo rming proteins were prepared from E. coli LE392 transformed with pEH90-10am and were separated by SDS PAGE. The gel slice containing the Cro-gD-1 protein was excised, macerated, and emulsified in complete Freund's adju vant. Two rabbits (R327 and R328) were inoculated with 200 f,lg of protein at days 1, 28, 42, and 56. Serum was collected from these animals at days 0, 34, 48, 62, and 69 and used to immunoprecipitate authentic gD -1 radio labeled in HSV-1 in fected Vero cells. We fo und that high titers of immunoprecipi tating antibody were obtained after four inoculations of the antigen (Fig 12) . Even after two inoculations (at day 34), low titers of antibody were apparent in R327 serum. These results indicate that the Cro-gD-1 amber fragments are immunogenic in rabbits. The neutralization titers of these sera were fo und to be comparable with those obtained using Cro-gD-1-{3-gal pro teins as immunogens [6, 7] .
DISCUSSION
We have shown here that specific polypeptide sequences of HSV -1 and HSV -2 glycoprotein D can be made in quantity in E. coli. Rabbits inoculated with these antigens produced anti bodies that recognized authentic gD-1 and gD -2 and that neu tralized the infectivity of both HSV -1 and HSV -2 in vitro. The ability to make defined protein sequences in large quantity should fa cilitate studies of the fu nction of these viral polypeptides and should also provide a means to produce antigens of high quality and safety for use as diagnostic reagents and immunogens.
The precise fu nction of gD -l and gD -2 in the HSV replication cycle is unknown. However, the ability of certain monoclonal antibodies to gD to neutralize virus infectivity in the absence of complement [20, 33] indicates a role for this glycoprotein in absorption of the virus to cells. Glycoprotein gD appears to be involved also in fu sion of infected cells, since anti-gD mono clonals inhibit this phenomenon [24] . The polypeptide se quences involved in these properties may be examined by raising antibodies to defined regions of the gD structure and testing whether such antibodies are able to inhibit these fu nc tions.
The central role of gD in the infectivity of HSV and the ability of this virus to pass from cell to cell, by cell fusion, without scrutiny by the humoral immune system may indicate that gD is a prime target for the eventual prevention and therapy of herpes simplex virus disease. The history of vacci nation in control of human herpesvirus infections, while quite long, is not very distinguished [25] . However, positive indica tions of the effectiveness of an HSV vaccine in preventing and treating herpes genitalis has recently been obtained by Skin ner and colleagues [26] . It is our intention to study the effectiven ess
